{"basic_info": {"ticker": "2181", "exchange": "XHKG", "bloomberg_ticker": "2181 HK Equity", "name": "MABPHARM LTD", "industry": "Biotechnology", "name_chinese_simplified": "迈博药业", "period": "2020", "market_value": 4330284032, "total_income": 32237000, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 22779000, "business_income_over_total_income": 0.7066104166020412}, {"shariah_compliance": "non-compliant", "income": 9458000, "business_income_over_total_income": 0.29338958339795884}, {"shariah_compliance": "unknown", "income": 0, "business_income_over_total_income": 0.0}], "details": [{"business_activity_cn": "银行利息收入", "business_activity_en": "Bank interest income", "income": 9458000, "business_income_over_total_income": 0.29338958339795884, "shariah_compliance": "non-compliant"}, {"business_activity_cn": "与收入有关的政府补助及补贴", "business_activity_en": "Government grants and subsidies to income-related", "income": 22779000, "business_income_over_total_income": 0.7066104166020412, "shariah_compliance": "compliant"}, {"business_activity_cn": "销售原材料所得收入", "business_activity_en": "Sales of raw materials income", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "compliant"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.010985067502579219, "shariah_compliance": "compliant", "amount_over_market_value": 0.010985067502579219}]}